RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70.
Saved in:
| Title: | RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70. |
|---|---|
| Authors: | Shevtsov M; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia., Yudintceva N; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia., Bobkov D; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.; Smorodintsev Research Institute of Influenza, St. Petersburg, Russia., Likhomanova R; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia., Nechaeva A; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Mikhailova E; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Oganesyan E; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Fedorov V; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Kurkin A; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia., Lukacheva A; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia., Fofanov G; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Kim A; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Fedorov E; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Sitovskaya D; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia., Ulitin A; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia., Mikhailova N; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Anufriev I; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Istomina M; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Murashko E; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Kessenikh E; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Aksenov N; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia., Vakhitova Y; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Samochernykh K; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia., Pitkin E; Department of Statistics and Data Science, Wharton School, University of Pennsylvania, Philadelphia, PA, United States., Shlyakhto E; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia., Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Mar 24; Vol. 15, pp. 1543657. Date of Electronic Publication: 2025 Mar 24 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40196735 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shevtsov+M%22">Shevtsov M</searchLink>; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Yudintceva+N%22">Yudintceva N</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Bobkov+D%22">Bobkov D</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.; Smorodintsev Research Institute of Influenza, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Likhomanova+R%22">Likhomanova R</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Nechaeva+A%22">Nechaeva A</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Mikhailova+E%22">Mikhailova E</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Oganesyan+E%22">Oganesyan E</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Fedorov+V%22">Fedorov V</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Kurkin+A%22">Kurkin A</searchLink>; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Lukacheva+A%22">Lukacheva A</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Fofanov+G%22">Fofanov G</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Kim+A%22">Kim A</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Fedorov+E%22">Fedorov E</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Sitovskaya+D%22">Sitovskaya D</searchLink>; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Ulitin+A%22">Ulitin A</searchLink>; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Mikhailova+N%22">Mikhailova N</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Anufriev+I%22">Anufriev I</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Istomina+M%22">Istomina M</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Murashko+E%22">Murashko E</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Kessenikh+E%22">Kessenikh E</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Aksenov+N%22">Aksenov N</searchLink>; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Vakhitova+Y%22">Vakhitova Y</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Samochernykh+K%22">Samochernykh K</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Pitkin+E%22">Pitkin E</searchLink>; Department of Statistics and Data Science, Wharton School, University of Pennsylvania, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Shlyakhto+E%22">Shlyakhto E</searchLink>; Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.<br /><searchLink fieldCode="AU" term="%22Combs+SE%22">Combs SE</searchLink>; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Mar 24; Vol. 15, pp. 1543657. <i>Date of Electronic Publication: </i>2025 Mar 24 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40196735 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1543657 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1543657 Titles: – TitleFull: RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shevtsov M – PersonEntity: Name: NameFull: Yudintceva N – PersonEntity: Name: NameFull: Bobkov D – PersonEntity: Name: NameFull: Likhomanova R – PersonEntity: Name: NameFull: Nechaeva A – PersonEntity: Name: NameFull: Mikhailova E – PersonEntity: Name: NameFull: Oganesyan E – PersonEntity: Name: NameFull: Fedorov V – PersonEntity: Name: NameFull: Kurkin A – PersonEntity: Name: NameFull: Lukacheva A – PersonEntity: Name: NameFull: Fofanov G – PersonEntity: Name: NameFull: Kim A – PersonEntity: Name: NameFull: Fedorov E – PersonEntity: Name: NameFull: Sitovskaya D – PersonEntity: Name: NameFull: Ulitin A – PersonEntity: Name: NameFull: Mikhailova N – PersonEntity: Name: NameFull: Anufriev I – PersonEntity: Name: NameFull: Istomina M – PersonEntity: Name: NameFull: Murashko E – PersonEntity: Name: NameFull: Kessenikh E – PersonEntity: Name: NameFull: Aksenov N – PersonEntity: Name: NameFull: Vakhitova Y – PersonEntity: Name: NameFull: Samochernykh K – PersonEntity: Name: NameFull: Pitkin E – PersonEntity: Name: NameFull: Shlyakhto E – PersonEntity: Name: NameFull: Combs SE IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 03 Text: 2025 Mar 24 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |